Some metabolic modulators, including the pyruvate dehydrogenase kinase inhibitor dichloroacetate (DCA) and the biguanide metformin, sensitize melanoma cells to BRAF inhibitors18,19. The gene discussed is BRAF; the disease is melanoma.